Reportedly, Israel’s DayTwo raised $31 million in private financing bringing in a total of $48 million funding for the health tech start-up. DayTwo existing investors Seventure Partners and Johnson & Johnson were also participants at the event. DayTwo provides nutritional insights on intestinal bacteria and has received previous funding from the Mayo Clinic for the company’s validation trial.
The Israeli Health Tech was founded in 2015 and has two offices in Tel Aviv and San Francisco. They are reported to be planning to use funds raised to advance initiatives in the United States partnering with payers, providers, and employers and contributing to developing new products for metabolic and gastrointestinal conditions.
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!